EASTLAND JULIA MARIE 4
4 · Zentalis Pharmaceuticals, Inc. · Filed Dec 3, 2024
Insider Transaction Report
Form 4
EASTLAND JULIA MARIE
DirectorCEO & President
Transactions
- Award
Stock Option (Right to Buy)
2024-12-02+3,028,800→ 3,028,800 totalExercise: $3.66Exp: 2034-12-02→ Common Stock (3,028,800 underlying)
Footnotes (1)
- [F1]The options will vest over a four-year period following the vesting commencement date of November 13, 2024, in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.